Pharma export grows over 9% in September 2023

October 18, 2023
News
1 mins read

Source: Pharmabiz

Exports of pharmaceutical products from the country have reported a 9.02% growth during the month of September as compared to the same period of previous year. For the first six months of the current fiscal year, the exports have posted a 5.02 per cent growth.

According to data from the Central Government, the exports during the month of September, 2023 stood at $2.39 billion as compared to $2.19 billion during the same month of last year.

The growth compared to the exports of $2.24 billion in the previous month of August is around 6.7 per cent.

For the six months from April to September, 2023, the exports were at $13.36 billion as compared to $12.72 billion reported during the same period of previous year.

Imports have reported a 3.38 per cent growth during the month of September, at $623.48 million as compared to $603.11 million registered during the same month of last year. The cumulative imports from April to September, 2023 grew marginally to $4.07 billion as compared to $4.06 billion during the same period of previous fiscal year.

The Ministry of Health and Family Welfare in June, this year, said that India’s drug and pharmaceutical products exports grew by 125 per cent from Rs. 90,415 Crore in 2013-14 to Rs. 2,04,110 Crore in 2022-23.

Drugs and Pharmaceuticals exports constitute 5.71 per cent of the total exports from India. India ranks 3rd worldwide for the production of Drugs and Pharmaceuticals by volume exporting to around 200 countries/territories with the top 5 destinations being the USA, Belgium, South Africa, UK, and Brazil.

India accounts for 60 per cent of global vaccine production making it the largest vaccine producer in the world. India is also one of the biggest suppliers of low-cost vaccines in the world and is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume.

“Further, India has supplied over 298 million COVID-19 vaccines to around 100 countries across the globe under Vaccine Maitri initiative (till May 19, 2023),” said the Ministry. It added that an investment of Rs 21,861 crore was received under PLI Schemes till June.

Pharmaways

Pharmaways Global Private Limited is a company established in 2022. Headed by a group of professionals with over 25 years of experience. A team of professionals who have excelled in their respective fields of Pharma, Legal & Information Technology. We have global exposure and hands-on experience of the global Pharma industry. We are in pursuit of bringing the global Pharma Industry on a platform where they can connect, collaborate and work towards mutual growth. We have taken a step into the future by innovating a technology that will help global Pharma players to empower, excel and accelerate in their business. A platform that has been developed exclusively for the Pharma fraternity. We are a New Delhi based company with overseas offices in America and the United Kingdom.